Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

Some tidbits on the DB CC call this am.

Craig said continuing to show good results on phase 11 Necuparanib.

Said the investment community should start to think of us as an autoimmune company. Smart move in my opinion.

Starting clinical trial in two weeks on our autoimmune drug.

Looking at outside the US sales of Glatopa.

Thinks the 6 months heads up on exclusivity will eventually go away. That will help.

Thinks the current FDA is becoming more receptive to our position on how the approval process should evolve to keep costs down. My words on what he said.

Said they are getting ready for the launch of 3 times a week Glatopa. 1st quarter.

It was again mentioned over 3 years of cash. Also a new drug each year by 2019

As always listen to the CC yourself. Sort of garbled on the sound this am.

Boing X 2